Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity | Molecular Cancer Therapeutics | American Association for Cancer Research https://t.co/OhDajEsKWY
449 followers
149 followers
RT @K9FCR: Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immu…
15,829 followers
An article to talk about good orthopoxviruses (not just monkeypox). An onclolytic virus with pox backbone (cancer killing) phase 1 trial to test for patients with solid tumors who failed 2 prior therapies. https://t.co/TCsgffLPHf
12,700 followers
Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity https://t.co/mEKxcoD4WS